Clin2
NCT07618156Likely a fitNot yet recruiting

Safety and Effects of KR25102 in Healthy Adults

Healthy Volunteers (HV)

This early-stage trial tests a new investigational drug called KR25102 in healthy volunteers to see how safe it is and how the body processes it. The study also includes optional pain-sensitivity testing for some participants.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
83 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • Be between 18 and 55 years old
  • Have a healthy weight (BMI 19–26) and weigh at least 50 kg if male or 45 kg if female
  • Not be pregnant, breastfeeding, or planning to conceive for at least 2 months after the study ends
  • Not have any serious medical conditions (heart, lung, diabetes, mental health, cancer, etc.)
  • Not have taken other medications or supplements in the past 2 weeks
  • Not have hepatitis B, hepatitis C, HIV, or syphilis

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07474545Recruiting· Phase 1
Safety study of KL0011034 injection in healthy volunteers

This trial tests a new injection called KL0011034 to see if it is safe and how the body processes it. Healthy volunteers aged 18–45 who meet specific health and lifestyle criteria can join.

Changsha, Hunan
NCT07301333Recruiting· Phase 1
Study of HRS-6257 in healthy volunteers

This study tests a new investigational drug called HRS-6257 in healthy volunteers. It looks at how the drug works in the body and checks for side effects after one or several doses.

Changsha, Hunan
NCT07409922Recruiting· Phase 1
Testing KR23343 in healthy volunteers

This study tests a new medicine, KR23343, in healthy adults to see how the body handles it at different doses. It helps find the right dose and check for any early side effects.

Shanghai
NCT07585383Not yet recruiting· Phase 1
Safety study of KR23248 in healthy adults

This is an early-stage study testing a new experimental drug called KR23248 in healthy volunteers to see if it is safe and how the body processes it. Researchers want to understand potential side effects and how the drug moves through your system.

NCT07501039Recruiting· Phase 1
First test of BLKR201 in healthy adults

This study tests a new medicine, called BLKR201, for the first time in people. It is given to healthy volunteers to see how safe it is and how the body handles it.

Lincoln, Nebraska
NCT07580794Recruiting· Phase 1
Safety Study of New Drug HSK56630 in Healthy People

This is an early-stage safety test of a new investigational drug called HSK56630 in healthy volunteers with no major medical conditions. Researchers will monitor how your body tolerates the drug and what side effects might occur.

Bayswater, Victoria

Hear when a new Healthy Volunteers (HV) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.